Navigation Links
Nasseo Wins CONNECT Life Sciences Capital Competition and Joins CONNECT Portfolio

San Diego, CA (PRWEB) March 12, 2013

Nasseo, Inc. is honored to announce that it has won CONNECT’s Life Sciences Capital Competition and has subsequently earned the distinction of becoming a CONNECT Portfolio Company. Competing against a large pool of highly qualified California-based life science companies, Nasseo was selected by a panel of distinguished judges for its “radical innovation in the Southern California start-up scene”. Pursuant to its victory, the Company has been invited to present its proprietary implant surface modification technology for dental and orthopedic applications to a group of venture capital investors at the March 14th Capital Roadshow in Palo Alto, California at the offices of Morrison & Foerster.

Nasseo’s first product, the TiArray™ Dental Implant is an easy-to-use, cost-effective dental implant system for patients with poor circulatory issues (e.g. diabetics, smokers) as well as for the general population. Nasseo’s technology addresses the ongoing problem of dental implant failures, which account for $1.2B annually in patient healthcare costs in the United States.

Nasseo’s selection earlier this year to CONNECT Springboard, a distinguished business mentorship and networking program, was a key milestone for the company. The CONNECT Springboard program introduced Nasseo to serial life sciences entrepreneur Bill Gerhart for executive mentorship. Mr. Gerhart was previously Founder, President & CEO of Elevation Pharmaceuticals, which developed new aerosol therapies for underserved respiratory patient populations, and which he sold in 2012 to Sunovion Pharmaceuticals for up to $430 million. After undergoing a rigorous screening and completing the mentoring process with Gerhart, Nasseo was further vetted to present in the CONNECT Life Sciences Capital Competition.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo says, “Bill Gerhart has successfully led several life sciences companies through the growth stages that Nasseo is now experiencing. His insight on how to strategically position the company for investment was instrumental. We are grateful for his continued support.”

Nasseo’s TiArray™ dental implant product and its proprietary technology have drawn significant interest from the scientific and investment communities. Last year, the company presented at World’s Best Technology (WBT) Innovation Marketplace 2012, and also received the 1st place prize at the 6th Annual UC San Diego Entrepreneur Challenge Business Plan Competition, where it was the first startup to ever win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year. Nasseo most recently announced that it had been selected into the BioInspire™ medical technology incubator, and had subsequently closed its $520K seed round of funding.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo, says, “CONNECT has offered us a number of dynamic opportunities to grow our company. We look forward to the opportunity to introduce the Nasseo TiArray™ dental implant system to a new audience of VCs at the March 14th Capital Roadshow.”

Additionally, CONNECT has invited Nasseo to be one of eight emerging companies across all disciplines to present at its annual Rock Stars of Innovation Summit in San Diego on April 12, a premier showcase at the Hard Rock Hotel to be attended by over 250 technology and investment leaders. The company is moving forward with plans to raise a $3M+ Series A investment round in mid 2013 to catalyze production and sales.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in San Diego, CA. For more information, please visit us at or contact us at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
2. Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0
3. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. Launched, a Unique Life Science Business Networking Site
6. Excel Life Sciences Joins DATATRAKs Connect Partner Program
7. Blue Brain Project accurately predicts connections between neurons
8. Low-resistance connections facilitate multi-walled carbon nanotubes for interconnects
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. CureLauncher is a New Website That Connects Patients to Trials Across the U.S.
11. Aspiring Photonics Entrepreneurs to Vie for Prizes, Connections in SPIE Startup Challenge
Post Your Comments:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):